Description
Colivelin
Disclaimer: The compounds described on this page are intended for laboratory research use only and are not approved for human consumption.
Overview of Colivelin
Colivelin is a synthetic peptide composed of two functional segments. The peptide is made of two main components. One part is a humanin derivative (AGA-(C8R)HNG) and an ADNF (Activity-Dependent Neurotrophic Factor) peptide fragment. As a hybrid peptide, it was synthesized to potentiate the neuroprotective effect of humanin.
Researchers study Colivelin for its potential role in neuroprotection and neuronal survival.
| Section | Details |
| CAS Number | 867021-83-8 (r) |
| Molar Mass | 2645.10 g/mol |
| Chemical Formula | C119H206N32O35 |
| Chemical Sequence | H-Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Pro-Ala-Gly-Ala-Ser-Arg-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-OH. |
| Synonyms | Remacemide hydrochloride |
| Ingredients / Composition | Lyophilized white powder in a sterile vial |
| Shelf Life | 6-12 months if stored properly |
| Storage Instructions | Once reconstituted, store in the refrigerator (2–8°C or 36–46°F). |
| Disclaimer | This product is intended for research use only and is not approved for human or veterinary consumption. |
Why Consider Colivelin Peptide for Research?
Researchers may consider Colivelin Peptide based on its intended research application, available specifications, and supporting documentation.
- Colivelin’s potential to improve neuronal survival signalling and lessen neurotoxicity in models of Alzheimer’s disease is a key area of its research interest.
- It may be a key component in neurodegenerative diseases. Primarily studied for its role in mitochondrial dysfunction in nerve cells.
- Colivelin’s 99% purity has been third-party certified, guaranteeing complete transparency.
Researchers may consider Colivelin Peptide based on its intended research application, available specifications, and supporting documentation.
Frequently Asked Questions (FAQs)
How does Colivelin work?
According to research, Colivelin may have possible effects on the brain cells of clinical models. Studies show this may be due to a potential interaction with a protein called STAT3 (Signal Transducer and Activator of Transcription 3).
Additionally, it may affect other regions linked to brain diseases in clinical models. This includes:
- Potentially improving neuronal survival signalling in clinical settings.
- Aiding in Alzheimer’s disease by potentially reducing neurotoxicity.
- Potential for activating STAT3/JAK2 pathways in experimental models.
What are the side effects of Colivelin?
Colivelin is still under investigation. As a result, its potential side effects in clinical models are unknown. More research is required to confirm the exact side effects.
Is Colivelin approved for human use?
What should be verified before sourcing Colivelin Peptide?
Readers should review the vendor’s identity, purity, and batch-testing documentation for Colivelin Peptide and confirm that the material is used only within applicable laboratory research requirements.
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
